Timing of myocarditis onset during immunotherapy for cancer may predict mortality risk

The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed myocarditis within a month of starting immune checkpoint inhibitors (ICI) appeared more than twice as likely to die of the rare but potentially serious adverse event than those who developed it between

Raccontata dahealio.com